Publications by authors named "Margriet Collee"

Claim this Profile
E
Evidence for pathogenicity of c.8351G>A p.(Arg2784Gln) and the challenges in classification of pathogenic variants with reduced penetrance.
Setareh Moghadasi, Maria Zanti, Fonnet Bleeker, Marinus Blok, Merel E Braspenning, Margriet J Collee

J Med Genet· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on bone mineral density.
Maarten J Beekman, Lara Terra, Anniek Stuursma, Bernadette A M Heemskerk-Gerritsen, Jeanine E Roeters van Lennep

Osteoporos Int· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No increased arterial stiffness after premenopausal risk-reducing salpingo-oophorectomy (RRSO).
Maarten J Beekman, Lara Terra, Jeanine E Roeters van Lennep, Bernadette A M Heemskerk-Gerritsen, Marc van Beurden

Maturitas· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Breast cancer; article for education and training purposes].
Carolien H Smorenburg, José H Volders, J Margriet Collée, Marie-Jeanne T F D Vrancken Peeters

Ned Tijdschr Geneeskd· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular disease risk after breast cancer treatment in patients with a BRCA1/2 pathogenic variant.
Lara Terra, Naomi B Boekel, Maartje H Hooning, Margriet Collee, Marjanka K Schmidt

Breast Cancer Res Treat· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the recently established Dutch nationwide Archipelago of Ovarian Cancer Research biobank.
Hein S Zelisse, Mignon D J M van Gent, Constantijne H Mom, Sander de Ridder, Malou L H Snijders

Ann Diagn Pathol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Information Technology (IT) Infrastructure of the Multicenter Archipelago of Ovarian Cancer Research Biobank: A Potential Blueprint for Other Biobanks.
Hein S Zelisse, Sander de Ridder, Mignon D J M van Gent, Constantijne H Mom, G Bea A Wisman

Biopreserv Biobank· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary Artery Calcium Scores After Prophylactic Premenopausal Bilateral Salpingo-Oophorectomy.
Maarten J Beekman, Lara Terra, Bernadette A M Heemskerk-Gerritsen, Carlijn M van der Aalst, Jeanine E Roeters van Lennep

JACC CardioOncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families.
Maartje A C Schreurs, Marjanka K Schmidt, Antoinette Hollestelle, Michael Schaapveld, Christi J van Asperen

Genet Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset.
Aimee L Davidson, Kyriaki Michailidou, Michael T Parsons, Cristina Fortuno, Manjeet K Bolla

Am J Hum Genet· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers.
Iris A S Stroot, Joost Bart, Harry Hollema, Mathilde Jalving, Marise M Wagner

Gynecol Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the BOADICEA model in a prospective cohort of pathogenic variant carriers.
Xin Yang, Thea M Mooij, Goska Leslie, Lorenzo Ficorella, Nadine Andrieu, Margriet J Collee

J Med Genet· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families.
Maartje A C Schreurs, Teresa Ramón Y Cajal, Muriel A Adank, J Margriet Collée, Antoinette Hollestelle

Breast· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Urinary incontinence more than 15 years after premenopausal risk-reducing salpingo-oophorectomy: a multicentre cross-sectional study.
Lara Terra, Bernadette A M Heemskerk-Gerritsen, Maarten J Beekman, Ellen Engelhardt, Marian J E Mourits

BJOG· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel.
Hagai Levi, Shai Carmi, Saharon Rosset, Rinat Yerushalmi, Aviad Zick, Margriet J Collee

J Med Genet· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term effects of premenopausal risk-reducing salpingo-oophorectomy on cognition in women with high familial risk of ovarian cancer: A cross-sectional study.
Lara Terra, Philippe R Lee Meeuw Kjoe, Joost A Agelink van Rentergem, Maarten J Beekman, Bernadette A M Heemskerk-Gerritsen

BJOG· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile.
Marcel Smid, Marjanka K Schmidt, Wendy J C Prager-van der Smissen, Kirsten Ruigrok-Ritstier, Maartje A C Schreurs

Breast Cancer Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy.
Lara Terra, Maarten J Beekman, Ellen G Engelhardt, Bernadette A M Heemskerk-Gerritsen, Marc van Beurden

Am J Obstet Gynecol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of the Dutch Nationwide, Interdisciplinary Infrastructure and Biobank for Fundamental and Translational Ovarian Cancer Research: Archipelago of Ovarian Cancer Research.
Hein S Zelisse, Mignon D J M van Gent, Sander de Ridder, Maaike A van der Aa, Anne M van Altena

Gynecol Obstet Invest· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer risks associated with missense variants in breast cancer susceptibility genes.
Leila Dorling, Sara Carvalho, Jamie Allen, Michael T Parsons, Cristina Fortuno

Genome Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of chemotherapy on contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: A nationwide cohort study.
Delal Akdeniz, Mark van Barele, Bernadette A M Heemskerk-Gerritsen, Ewout W Steyerberg, Michael Hauptmann

Breast· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Common variants in breast cancer risk loci predispose to distinct tumor subtypes.
Thomas U Ahearn, Haoyu Zhang, Kyriaki Michailidou, Roger L Milne, Manjeet K Bolla

Breast Cancer Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rare germline copy number variants (CNVs) and breast cancer risk.
Joe Dennis, Jonathan P Tyrer, Logan C Walker, Kyriaki Michailidou, Leila Dorling

Commun Biol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant.
Inge M M Lakeman, Alexandra J van den Broek, Juliën A M Vos, Daniel R Barnes, Julian Adlard

Genet Med· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
Juliette Coignard, Michael Lush, Jonathan Beesley, Tracy A O'Mara, Joe Dennis

Nat Commun· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis